Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Computerized Clinical Decision Support System for Prompting Brief Alcohol Interventions with Treatment Seeking Smokers: A Sex-Based Secondary Analysis of a Cluster Randomized Trial.

Minian N, Ivanova A, Voci S, Veldhuizen S, Zawertailo L, Baliunas D, Noormohamed A, Giesbrecht N, Selby P.

Int J Environ Res Public Health. 2020 Feb 6;17(3). pii: E1024. doi: 10.3390/ijerph17031024.

2.

Is cannabis use associated with tobacco cessation outcome? An observational cohort study in primary care.

Voci S, Zawertailo L, Baliunas D, Masood Z, Selby P.

Drug Alcohol Depend. 2020 Jan 1;206:107756. doi: 10.1016/j.drugalcdep.2019.107756. Epub 2019 Nov 20.

PMID:
31786396
3.

The effect of a clinical decision support system on prompting an intervention for risky alcohol use in a primary care smoking cessation program: a cluster randomized trial.

Minian N, Baliunas D, Noormohamed A, Zawertailo L, Giesbrecht N, Hendershot CS, Le Foll B, Rehm J, Samokhvalov AV, Selby PL.

Implement Sci. 2019 Aug 23;14(1):85. doi: 10.1186/s13012-019-0935-x.

4.

Predisposing and protective factors influencing suicide ideation, attempt, and death in patients accessing substance use treatment: a systematic review and meta-analysis protocol.

Espinet S, Corrin T, Baliunas D, Quilty L, Zawertailo L, Rizvi SJ, deRuiter W, Bonato S, De Luca V, Kennedy S, Selby P.

Syst Rev. 2019 May 15;8(1):115. doi: 10.1186/s13643-019-1028-2.

5.

Public health impact of a novel smoking cessation outreach program in Ontario, Canada.

Selby P, Voci S, Zawertailo L, Baliunas D, Dragonetti R, Hussain S.

BMC Public Health. 2018 Sep 14;18(1):1117. doi: 10.1186/s12889-018-6012-6.

6.

Tailored Versus Generic Knowledge Brokering to Integrate Mood Management Into Smoking Cessation Interventions in Primary Care Settings: Protocol for a Cluster Randomized Controlled Trial.

Minian N, Noormohamed A, Baliunas D, Zawertailo L, Mulder C, Ravindran A, de Oliveira C, Selby P.

JMIR Res Protoc. 2018 Apr 27;7(4):e111. doi: 10.2196/resprot.9715.

7.

A method for co-creation of an evidence-based patient workbook to address alcohol use when quitting smoking in primary care: a case study.

Minian N, Noormohamed A, Zawertailo L, Baliunas D, Giesbrecht N, Le Foll B, Rehm J, Samokhvalov A, Selby PL.

Res Involv Engagem. 2018 Feb 5;4:4. doi: 10.1186/s40900-018-0086-2. eCollection 2018.

8.

Target quit date timing as a predictor of smoking cessation outcomes.

Zawertailo L, Ragusila A, Voci S, Ivanova A, Baliunas D, Selby P.

Psychol Addict Behav. 2017 Sep;31(6):655-663. doi: 10.1037/adb0000301. Epub 2017 Jul 13.

PMID:
28703612
9.

Combining alcohol interventions with tobacco addictions treatment in primary care-the COMBAT study: a pragmatic cluster randomized trial.

Minian N, Baliunas D, Zawertailo L, Noormohamed A, Giesbrecht N, Hendershot CS, Le Foll B, Rehm J, Samokhvalov A, Selby PL.

Implement Sci. 2017 May 18;12(1):65. doi: 10.1186/s13012-017-0595-7.

10.

Concurrent E-Cigarette Use During Tobacco Dependence Treatment in Primary Care Settings: Association With Smoking Cessation at Three and Six Months.

Zawertailo L, Pavlov D, Ivanova A, Ng G, Baliunas D, Selby P.

Nicotine Tob Res. 2017 Feb;19(2):183-189. doi: 10.1093/ntr/ntw218. Epub 2016 Aug 31.

PMID:
27613911
11.

Individualized Treatment for Tobacco Dependence in Addictions Treatment Settings: The Role of Current Depressive Symptoms on Outcomes at 3 and 6 Months.

Zawertailo LA, Baliunas D, Ivanova A, Selby PL.

Nicotine Tob Res. 2015 Aug;17(8):937-45. doi: 10.1093/ntr/ntv013.

PMID:
26180218
12.

Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.

Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M.

Drug Alcohol Rev. 2010 Jul;29(4):437-45. doi: 10.1111/j.1465-3362.2009.00153.x. Review.

PMID:
20636661
13.

Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis.

Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, Rehm J.

BMC Public Health. 2010 May 18;10:258. doi: 10.1186/1471-2458-10-258. Review.

14.

The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, Parry CD, Patra J, Popova S, Poznyak V, Roerecke M, Room R, Samokhvalov AV, Taylor B.

Addiction. 2010 May;105(5):817-43. doi: 10.1111/j.1360-0443.2010.02899.x. Epub 2010 Mar 15.

15.

Causal considerations on alcohol and HIV/AIDS--a systematic review.

Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J.

Alcohol Alcohol. 2010 Mar-Apr;45(2):159-66. doi: 10.1093/alcalc/agp091. Epub 2010 Jan 8. Review.

PMID:
20061510
16.

Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis.

Baliunas D, Rehm J, Irving H, Shuper P.

Int J Public Health. 2010 Jun;55(3):159-66. doi: 10.1007/s00038-009-0095-x. Epub 2009 Dec 1.

PMID:
19949966
17.

Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis.

Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J.

Diabetes Care. 2009 Nov;32(11):2123-32. doi: 10.2337/dc09-0227.

18.

Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis.

Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, Rehm J.

Addiction. 2009 Dec;104(12):1981-90. doi: 10.1111/j.1360-0443.2009.02694.x. Epub 2009 Oct 5. Review.

PMID:
19804464
19.

Undergraduate drinking and academic performance: a prospective investigation with objective measures.

Thombs DL, Olds RS, Bondy SJ, Winchell J, Baliunas D, Rehm J.

J Stud Alcohol Drugs. 2009 Sep;70(5):776-85.

20.

The costs of alcohol, illegal drugs, and tobacco in Canada, 2002.

Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, Patra J, Sarnocinska-Hart A, Taylor B.

J Stud Alcohol Drugs. 2007 Nov;68(6):886-95.

PMID:
17960307
21.

Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002.

Baliunas D, Patra J, Rehm J, Popova S, Taylor B.

BMC Public Health. 2007 Sep 18;7:247.

22.
23.

Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy.

Baliunas D, Patra J, Rehm J, Popova S, Kaiserman M, Taylor B.

Chronic Dis Can. 2007;27(4):154-62.

24.

Illegal drug-attributable morbidity in Canada 2002.

Popova S, Rehm J, Patra J, Baliunas D, Taylor B.

Drug Alcohol Rev. 2007 May;26(3):251-63. Review.

PMID:
17454014
25.

Alcohol-attributable morbidity and resulting health care costs in Canada in 2002: recommendations for policy and prevention.

Taylor B, Rehm J, Patra J, Popova S, Baliunas D.

J Stud Alcohol Drugs. 2007 Jan;68(1):36-47.

PMID:
17149516
26.

[Willing to undergo hepatitis C treatment in a sample of injection drug users in Toronto, Canada].

Fischer B, Vasdev S, Haydon E, Baliunas D, Rehm J.

Presse Med. 2005 Oct 8;34(17):1209-12. French.

27.

Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, El-Guebaly N, Noël L, Tyndall M, Wild C, Mun P, Baliunas D.

J Urban Health. 2005 Jun;82(2):250-66. Epub 2005 May 4.

28.

Determinants of overdose incidents among illicit opioid users in 5 Canadian cities.

Fischer B, Brissette S, Brochu S, Bruneau J, el-Guebaly N, Noël L, Rehm J, Tyndall M, Wild C, Mun P, Haydon E, Baliunas D.

CMAJ. 2004 Aug 3;171(3):235-9.

Supplemental Content

Loading ...
Support Center